Hyperion DeFi (NASDAQ:HYPD) Insider Hyunsu Jung Buys 7,000 Shares

Hyperion DeFi, Inc. (NASDAQ:HYPD) insider Hyunsu Jung bought 7,000 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was acquired at an average cost of $3.70 per share, with a total value of $25,900.00. Following the transaction, the insider owned 1,384,676 shares of the company’s stock, valued at $5,123,301.20. This trade represents a 0.51% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Hyunsu Jung also recently made the following trade(s):

• On Tuesday, June 2nd, Hyunsu Jung acquired 1,000 shares of Hyperion DeFi stock. The shares were purchased at an average price of $3.66 per share, with a total value of $3,660.00.

Hyperion DeFi Stock Down 4.1%

Shares of NASDAQ:HYPD traded down $0.16 during midday trading on Tuesday, hitting $3.70. 613,834 shares of the stock were exchanged, compared to its average volume of 432,411. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.97 and a current ratio of 1.97. Hyperion DeFi, Inc. has a 52-week low of $1.71 and a 52-week high of $17.18. The business’s fifty day simple moving average is $3.65 and its two-hundred day simple moving average is $3.66. The company has a market capitalization of $56.08 million, a PE ratio of -0.37 and a beta of 2.48.

Hyperion DeFi (NASDAQ:HYPD) last announced its quarterly earnings data on Thursday, March 26th. The company reported ($7.76) earnings per share (EPS) for the quarter. The company had revenue of $0.50 million during the quarter. As a group, research analysts predict that Hyperion DeFi, Inc. will post 1.78 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Hyperion DeFi

Several institutional investors have recently bought and sold shares of the stock. Redwood Wealth Management Group LLC raised its holdings in Hyperion DeFi by 2.1% during the first quarter. Redwood Wealth Management Group LLC now owns 183,273 shares of the company’s stock valued at $632,000 after buying an additional 3,690 shares in the last quarter. Sanctuary Advisors LLC bought a new position in Hyperion DeFi during the fourth quarter valued at about $38,000. Nations Financial Group Inc. IA ADV bought a new position in Hyperion DeFi during the fourth quarter valued at about $40,000. Price T Rowe Associates Inc. MD bought a new position in Hyperion DeFi during the fourth quarter valued at about $73,000. Finally, Formidable Asset Management LLC bought a new position in Hyperion DeFi during the fourth quarter valued at about $83,000. 25.84% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

HYPD has been the subject of several recent research reports. Cantor Fitzgerald upgraded Hyperion DeFi to a “strong-buy” rating in a report on Thursday, April 9th. Zacks Research lowered Hyperion DeFi from a “hold” rating to a “strong sell” rating in a report on Monday, March 30th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Hyperion DeFi in a report on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $5.88.

About Hyperion DeFi

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.